Established Expertise Seattle Skin Cancer Center has a long-standing presence since 2000, founded by a pioneer in skin cancer treatment and Mohs micrographic surgery, indicating a strong reputation and deep expertise in dermatologic oncology.

Growing Patient Base With over 12,000 surgeries performed and more than 150 referring physicians, the center demonstrates high patient volumes and extensive professional network potential for partnership opportunities.

Market Segment Focusing on skin cancer diagnosis and treatment within outpatient settings, the company serves a niche market with strong demand driven by increasing skin cancer cases, offering opportunities for specialized product or service offerings.

Financial Range Revenue estimates between 1 million and 10 million dollars suggest a sizable but not dominant operation, indicating potential for growth partnerships, technology upgrades, or service expansion to scale their capabilities.

Limited Workforce With only one or no employees visible, the center may benefit from support solutions related to clinic management, staffing, or patient care technology to enhance operational efficiency and service capacity.